{
    "type": "ETC",
    "ucits": false,
    "leverage": true,
    "derivatives": true,
    "swaps": false,
    "inverse": false,
    "replication_method": "synthetic",
    "complex_factors": "Leverage, Derivatives, Synthetic replication, Daily reset compounding, Commodity futures roll costs",
    "classification": "complex",
    "supporting_data": "The WisdomTree Silver 2x Daily Leveraged product is an Exchange Traded Commodity (ETC), not a UCITS ETF, and thus 'ucits' is false. It provides 2x leveraged exposure to the Bloomberg Silver Sub Excess Return Index via futures contracts, implying synthetic replication through derivatives. The product uses derivatives integral to its investment objective, with leverage reset daily, causing compounding effects that make returns over periods longer than one day deviate from simple multiples of the index. This daily leverage reset and exposure to futures rolling costs (contango/backwardation) introduce complexity. The product is fully collateralised but involves counterparty risk inherent in derivatives. The KID explicitly states it is a high-risk (7/7) product, intended for informed investors with specific knowledge and experience, and warns that it is 'not simple and may be difficult to understand.' According to MiFID II Article 254 and Delegated Regulation EU 2017/565 Article 57, such use of derivatives for achieving the investment objective, significant leverage, synthetic replication, and complex payoff structures classify the product as complex. The product does not qualify for the UCITS non-complex presumption, and the presence of leverage and derivatives mandates classification as complex. Therefore, an appropriateness assessment is required before sale to retail investors under MiFID II rules."
}